Li Juan, Wang Jing, Li Ming, Yin Linlin, Li Xiang-An, Zhang Ting-Guo
Department of Pathology, Shandong University School of Medicine, Jinan, Shandong 250012, China; Department of Pathology, The Fourth Hospital of Jinan, Jinan, Shandong 250031, China.
Department of Pathology, The Fourth Hospital of Jinan, Jinan, Shandong 250031, China.
Pathol Res Pract. 2016 Jun;212(6):555-9. doi: 10.1016/j.prp.2016.03.011. Epub 2016 Mar 31.
Scavenger receptor class B type 1 (SR-B1) is an integral membrane protein that is expressed in numerous cells and tissue types. The primary role of SR-B1 is to facilitate uptake of cholesteryl esters from high-density lipoproteins (HDL) in the liver. Altered SR-B1 expression contributes to human diseases. This study assessed association of SR-B1 expression in breast tissue specimens with breast cancer development and prognosis. Tissue specimens from 30 cases of adjacent normal breast tissues, ductal carcinoma in situ (DCIS) and invasive ductal breast cancer (IDCA) were subjected to Western blot analysis, and 135 cases of DCIS and IDCA were used for quantitative immunohistochemical analysis of SR-B1 expression. The data showed that SR-B1 was significantly overexpressed in IDCA tissues compared to normal breast and DCIS tissues. SR-B1 expression was associated with pre-menopausal status, tumor size, and worse overall survival of patients. The data from this ex vivo study suggests that up-regulated SR-B1 protein expression is associated with malignant behaviors of breast cancer and that SR-B1 is an independent predictor for poor survival in breast cancer patients.
B1型清道夫受体(SR-B1)是一种整合膜蛋白,在多种细胞和组织类型中表达。SR-B1的主要作用是促进肝脏中高密度脂蛋白(HDL)的胆固醇酯摄取。SR-B1表达的改变与人类疾病有关。本研究评估了乳腺组织标本中SR-B1表达与乳腺癌发生发展及预后的相关性。对30例相邻正常乳腺组织、原位导管癌(DCIS)和浸润性导管癌(IDCA)的组织标本进行蛋白质印迹分析,并对135例DCIS和IDCA进行SR-B1表达的定量免疫组化分析。数据显示,与正常乳腺组织和DCIS组织相比,IDCA组织中SR-B1明显过表达。SR-B1表达与绝经前状态、肿瘤大小以及患者较差的总生存率相关。这项体外研究的数据表明,SR-B1蛋白表达上调与乳腺癌的恶性行为有关,并且SR-B1是乳腺癌患者生存不良的独立预测因子。